Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Biomed Microdevices ; 21(4): 101, 2019 11 23.
Article in English | MEDLINE | ID: mdl-31760501

ABSTRACT

E-cadherin is a cell-cell adhesion protein that plays a prominent role in cancer invasion. Inactivation of E-cadherin in breast cancer can arise from gene promoter hypermethylation or genetic mutation. Depending on their E-cadherin status, breast cancer cells adopt different morphologies with distinct invasion modes. The tumor microenvironment (TME) can also affect the cell morphology and invasion mode. In this paper, we used a previously developed microfluidic system to quantify the three-dimensional invasion of breast cancer cells with different E-cadherin status, namely MCF-7, CAMA-1 and MDA-MB-231 with wild type, mutated and promoter hypermethylated E-cadherin, respectively. The cells migrated into a stable and reproducible microfibrous polycaprolactone mesh in the chip under a programmed stable chemotactic gradient. We observed that the MDA-MB-231 cells invaded the most, as single cells. MCF-7 cells collectively invaded into the matrix more than CAMA-1 cells, maintaining their E-cadherin expression. The CAMA-1 cells exhibited multicellular multifocal infiltration into the matrix. These results are consistent with what is seen in vivo in the cancer biology literature. In addition, comparison between complete serum and serum gradient conditions showed that the MDA-MB-231 cells invaded more under the serum gradient after one day, however this behavior was inverted after 3 days. The results showcase that the microfluidic system can be used to quantitatively assess the invasion behavior of cancer cells with different E-cadherin expression, for a longer period than conventional invasion models. In the future, it can be used to quantitatively investigate effects of matrix structure and cell treatments on cancer invasion.


Subject(s)
Breast Neoplasms/pathology , Cadherins/metabolism , Cytological Techniques/instrumentation , Lab-On-A-Chip Devices , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Humans , Neoplasm Invasiveness
2.
Biomed Microdevices ; 19(4): 92, 2017 Oct 17.
Article in English | MEDLINE | ID: mdl-29038872

ABSTRACT

A major challenge in studying tumor cell invasion into its surrounding tissue is to identify the contribution of individual factors in the tumor microenvironment (TME) to the process. One of the important elements of the TME is the fibrous extracellular matrix (ECM) which is known to influence cancer cell invasion, but exactly how remains unclear. Therefore, there is a need for new models to unravel mechanisms behind the tumor-ECM interaction. In this article, we present a new microfabrication method, called selective curing, to integrate ECM-mimicking layers between two microfluidic channels. This method enables us to study the effect of 3D matrices with controlled architecture, beyond the conventionally used hydrogels, on cancer invasion in a controlled environment. As a proof of principle, we have integrated two electrospun Polycaprolactone (PCL) matrices with different fiber diameters in one chip. We then studied the 3D migration of MDA-MB-231 breast cancer cells into the matrices under the influence of a chemotactic gradient. The results show that neither the invasion distance nor the general cell morphology is affected significantly by the difference in fiber size of these matrices. The cells however do produce longer and more protrusions in the matrix with smaller fiber size. This microfluidic system enables us to study the influence of other factors in the TME on cancer development as well as other biological applications as it provides a controlled compartmentalized environment compatible with cell culturing.


Subject(s)
Biomimetics , Extracellular Matrix/chemistry , Lab-On-A-Chip Devices , Cell Line, Tumor , Humans , Hydrogels/chemistry , Microchip Analytical Procedures , Microtechnology , Models, Theoretical , Neoplasm Invasiveness , Tumor Microenvironment
3.
J Clin Pathol ; 61(5): 637-41, 2008 May.
Article in English | MEDLINE | ID: mdl-18227140

ABSTRACT

AIMS: Cervical cytology biobanking is a feasible concept in cervical pathology and could be an indispensable tool for fundamental and applied molecular biological research. PCR is a powerful molecular technique that can be performed on a variety of cervical sample types including Pap-stained cervical smears. However, since the quality of DNA from such specimens is inferior to that from fresh tissue, the correct processing methods are required. This study evaluates three commercial isolation methods and one digestion procedure for their ability to obtain DNA suitable for PCR from fixed and stained Pap smears. METHODS: The High Pure PCR Template Preparation kit, the NucliSENS easyMAG system, the QIAamp DNA Mini Kit and crude proteinase K digestion were used to obtain DNA for subsequent PCR applications. Amplification of beta-globin was performed to verify the presence and integrity of target DNA. The influence of PCR inhibitors and extent of DNA fragmentation were analysed. RESULTS: All commercial DNA isolation techniques provided DNA suitable for PCR amplification, and DNA isolated from 10-year-old archival smears yielded amplicons up to 400 base pairs. Conversely, crude proteinase K digestion limited the amplicon size to 300 bp and did not consistently yield amplifiable digests, as these were contaminated with PCR-inhibiting factors and debris. CONCLUSION: The study indicates that commercial DNA isolation techniques are suitable for PCR amplification of DNA isolated from archival smears, yielding amplicons up to 400 base pairs. Proteinase K digestion is not suitable to obtain amplifiable DNA from fixed and stained Pap-stained smears.


Subject(s)
Biological Specimen Banks , DNA/isolation & purification , Papanicolaou Test , Vaginal Smears , Female , Humans , Polymerase Chain Reaction/methods , Reagent Kits, Diagnostic , Specimen Handling/methods , Staining and Labeling
4.
J Clin Pathol ; 61(1): 132-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17468293

ABSTRACT

AIMS: Despite many improvements, cervical cancer screening is still subject to shortcomings. Diagnostic accuracy may improve by using molecular biological techniques, requiring RNA of superior quality. This study determined the effect of SurePath fixation on RNA integrity to assess the suitability of clinical samples collected in this medium for RNA-based molecular assays. METHODS: RNA isolation was performed on fresh and fixed HeLa cells and exfoliated cervical cells fixed in SurePath. The RNA integrity was evaluated by analysis of ribosomal RNA as an indicator of quality. The effect of SurePath preservation on PCR amplification was evaluated by real-time reverse transcriptase (RT)-PCR. RESULTS: In contrast to unfixed cells, SurePath-fixed cells yielded less and severely degraded RNA, as shown by the absence of ribosomal RNA bands. RNA derived from SurePath-fixed cells showed poor real-time RT-PCR amplification characteristics, as evidenced by the absent correlation between threshold values and log cDNA concentration. CONCLUSIONS: Implementation of molecular biology in a clinical context is on the rise and may alleviate shortcomings in current screening and diagnostics. This study shows that SurePath fixation gives rise to highly fragmented RNA with insufficient quality for further reliable analysis by standard real-time RT-PCR applications. The increasing prominence of molecular screening stresses the importance of this finding, which must be considered in relation to choice of an appropriate liquid-based cytology system.


Subject(s)
RNA, Neoplasm/isolation & purification , Tissue Fixation/methods , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears , Female , HeLa Cells , Humans , Mass Screening/methods , RNA, Neoplasm/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods
5.
J Clin Pathol ; 60(8): 896-901, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17660333

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) plays a critical role in the carcinogenesis of squamous cervical carcinoma. Integration of viral DNA into the host genome is a major contributing factor to malignant transformation. Viral load may influence integration. AIMS: To compare HPV status (type, viral load, integration status) between normal samples, carcinoma in situ and invasive carcinoma in order to elucidate the role of HPV in progression to invasive lesions. METHODS: The study population comprised 10 biopsy samples from each diagnostic group. Laminin-5 immunohistochemistry was performed to distinguish invasive carcinoma from non-invasive high-grade lesions. Real-time PCR was used to detect specific HPV types, viral load and integrated HPV, with quantification of viral E2 and E6 genes. RESULTS: Invasive carcinomas contained a higher number of laminin-5 immunoreactive cells as compared to non-invasive lesions. Almost all samples contained HPV, with a higher viral load and copy number of HPV16 integrated in E2 in cases of laminin-5 immunoreactivity and cases of invasive carcinoma. High HPV16 viral load was associated with more integrated copies in E2. CONCLUSIONS: HPV is important in progression from carcinoma in situ to invasive carcinoma. Viral load and HPV integration influence the development of cervical cancer towards invasiveness. Overall HPV status may be more predictive of patient outcome and may influence patient management.


Subject(s)
Carcinoma, Squamous Cell/immunology , Cell Adhesion Molecules/immunology , Papillomavirus Infections/genetics , Uterine Cervical Neoplasms/immunology , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/virology , DNA, Viral/genetics , Disease Progression , Female , Genes, Viral , HeLa Cells , Human papillomavirus 6/genetics , Humans , Immunohistochemistry/methods , Neoplasm Invasiveness , Papillomaviridae/genetics , Papillomavirus Infections/complications , Papillomavirus Infections/immunology , Uterine Cervical Neoplasms/complications , Uterine Cervical Neoplasms/virology , Viral Load , Uterine Cervical Dysplasia/complications , Uterine Cervical Dysplasia/immunology , Uterine Cervical Dysplasia/virology , Kalinin
6.
Braz. j. infect. dis ; 8(6): 465-468, Dec. 2004. ilus
Article in English | LILACS | ID: lil-401722

ABSTRACT

Tungiasis is caused by the penetration of the female sand flea Tunga penetrans into the epidermis, and subsequent hypertrophy of the parasite. In most cases lesions are confined to the feet. During a cross-sectional study, an unusual case of ectopic tungiasis in the inguinal area was detected. Histological examination of tissue samples showed a remarkable pseudoepitheliomatous aspect of the epidermis. Clinical features and differential diagnoses are discussed.


Subject(s)
Humans , Animals , Female , Child , Ectoparasitic Infestations/parasitology , Lymph Nodes/parasitology , Siphonaptera , Antinematodal Agents/therapeutic use , Cross-Sectional Studies , Ectoparasitic Infestations/drug therapy , Ectoparasitic Infestations/pathology , Hyperplasia/drug therapy , Hyperplasia/parasitology , Hyperplasia/pathology , Thiabendazole/therapeutic use
7.
Braz J Infect Dis ; 8(6): 465-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15880239

ABSTRACT

Tungiasis is caused by the penetration of the female sand flea Tunga penetrans into the epidermis, and subsequent hypertrophy of the parasite. In most cases lesions are confined to the feet. During a cross-sectional study, an unusual case of ectopic tungiasis in the inguinal area was detected. Histological examination of tissue samples showed a remarkable pseudoepitheliomatous aspect of the epidermis. Clinical features and differential diagnoses are discussed.


Subject(s)
Ectoparasitic Infestations/parasitology , Lymph Nodes/parasitology , Siphonaptera , Animals , Antinematodal Agents/therapeutic use , Child , Cross-Sectional Studies , Ectoparasitic Infestations/drug therapy , Ectoparasitic Infestations/pathology , Female , Humans , Hyperplasia/drug therapy , Hyperplasia/parasitology , Hyperplasia/pathology , Thiabendazole/therapeutic use
8.
Acta Clin Belg ; 58(4): 211-9, 2003.
Article in English | MEDLINE | ID: mdl-14635528

ABSTRACT

The causal relationship between genital human papillomavirus (HPV) infection and cervical dysplasia/carcinoma has been recognised for some time. The aim of this study was to document the occurrence and distribution of HPV infection in the five provinces of the Flemish region in Belgium and to correlate the HPV DNA test results with the cytological results on simultaneously performed thin layer preparations of cervical cells. Out of a total screened group of 105107 samples, 1978 samples with cytological abnormalities were tested for HPV DNA using the MY09/MY11 consensus PCR. The mean age of the whole group was 36.9 years. The LSIL group, with a mean age of 33.6 years, was significantly younger than the other groups. There was no significant difference in HPV prevalence among the provinces. In four out of five provinces the HPV prevalence reached 100% in high-grade lesions. There is a significant increase in predominance of high-risk HPV types, with increasing abnormal cytology (17.9% WNL < 51.1% ASCUS < 83.8% LSIL < 97.2% HSIL). Three peaks of HPV DNA positivity were observed, a first at 22 yrs (82%), a second at 47 yrs (60%) and a third in women older than 65 yrs (52%). These results shed more light on HPV prevalence in Flanders and show that the MY09/MY11 consensus primer based detection system is very suitable for the detection of HPV infections in Flanders.


Subject(s)
Papillomaviridae/isolation & purification , Papillomavirus Infections/epidemiology , Precancerous Conditions/epidemiology , Uterine Cervical Dysplasia/epidemiology , Uterine Cervical Neoplasms/epidemiology , Adult , Age Distribution , Aged , Analysis of Variance , Belgium/epidemiology , Biopsy, Needle , DNA, Viral/analysis , Female , Humans , Mass Screening , Middle Aged , Papillomavirus Infections/pathology , Polymerase Chain Reaction , Precancerous Conditions/pathology , Prevalence , Probability , Uterine Cervical Neoplasms/pathology , Uterine Cervical Dysplasia/pathology
9.
J Clin Pathol ; 56(9): 681-6, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12944552

ABSTRACT

AIMS: To test the ability of Ki-67 to detect cytological lesions in a screening setting and its use as a surrogate marker of human papillomavirus (HPV) infection. METHODS: A study of liquid based cytology, HPV DNA testing by MY09/MY11 consensus polymerase chain reaction (PCR), type specific PCRs, and Ki-67 immunocytochemistry on a randomly selected series of 147 patients. RESULTS: Comparison of the number of Ki-67 immunoreactive cells/1000 cells in the different cytological groups showed that the HSIL group yielded a significantly higher mean count than did the other groups. The number of Ki-67 immunoreactive cells/1000 cells was significantly higher in HPV-16 positive samples than in samples containing infections with other high risk types. Receiver operating characteristic curves indicated a test accuracy (area under curve) of 0.68, 0.72, and 0.86 for atypical squamous cells of undetermined significance (ASCUS), low grade squamous intraepithelial lesions (LSIL), and high grade squamous intraepithelial lesions (HSIL), respectively. Thresholds for 95% sensitivity were 0.07, 0.08, and 0.15 Ki-67 immunopositive cells/1000 cells for ASCUS, LSIL and HSIL, respectively. The threshold for 95% specificity was 1.9 Ki-67 immunopositive cells/1000 cells. CONCLUSIONS: Ki-67 immunocytochemistry can be applied to liquid based cytology. The accuracy and diagnostic indices of the test are good when compared with those of other techniques. As part of a panel of screening procedures, it could be used as an adjunct to liquid based cytology to identify HSIL, and as a surrogate marker of HPV-16 infection.


Subject(s)
Ki-67 Antigen/analysis , Papillomavirus Infections/diagnosis , Tumor Virus Infections/diagnosis , Uterine Cervical Diseases/diagnosis , Vaginal Smears , Biomarkers/analysis , DNA, Viral/analysis , Female , Humans , Immunohistochemistry/methods , Papillomaviridae/genetics , Polymerase Chain Reaction/methods , ROC Curve , Sensitivity and Specificity , Uterine Cervical Diseases/virology
10.
Am J Trop Med Hyg ; 65(3): 233-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11561710

ABSTRACT

Granulomatous inflammation of the cervix uteri is a common manifestation of infection with Schistosoma haematobium. In women the cervix is the most common site of infection by S. haematobium. Three methods were used to assess the performance of three different ways of detecting schistosome eggs in cervical tissue: cytological examination of a cervical smear, histological examination of a cervical biopsy, and direct examination of cervical tissue obtained by forceps biopsy (quantitative compressed biopsy technique [QCBT]). Of 228 women studied who lived in an S. haematobium endemic area in Tanzania, 112 (49%) had schistosome eggs detected in the cervix using QCBT. Histological examination detected eggs in 40 of 228 (18%). The cytological examination of cervical smears yielded only 6 positive results (3%). The median egg load in the cervical tissue of cases correctly diagnosed by histology was significantly higher than the egg load in the misclassified cases, indicating that the sensitivity of histological sectioning increases with egg density. We conclude that the QCBT is the diagnostic test of choice for schistosomiasis of the genital cervix.


Subject(s)
Schistosoma haematobium/isolation & purification , Schistosomiasis haematobia/diagnosis , Uterine Cervical Diseases/parasitology , Adolescent , Adult , Animals , Biopsy , Cervix Uteri/parasitology , Cervix Uteri/pathology , Cross-Sectional Studies , Female , Histocytochemistry , Humans , Middle Aged , Parasite Egg Count/methods , Schistosomiasis haematobia/pathology , Sensitivity and Specificity , Statistics, Nonparametric , Tanzania , Uterine Cervical Diseases/pathology , Vaginal Smears
SELECTION OF CITATIONS
SEARCH DETAIL
...